C

Serial Number 90322340
Registration 6454659
700

Registration Progress

Application Filed
Nov 16, 2020
Under Examination
Approved for Publication
Jun 1, 2021
Published for Opposition
Jun 1, 2021
Registered
Aug 17, 2021

Trademark Image

C

Basic Information

Serial Number
90322340
Registration Number
6454659
Filing Date
November 16, 2020
Registration Date
August 17, 2021
Published for Opposition
June 1, 2021
Drawing Code
5

Status Summary

Current Status
Active
Status Code
700
Status Date
Aug 17, 2021
Registration
Registered
Classes
005 042 044

Rights Holder

Curemark, LLC

16
Address
Suite 528 South
800 Westchester Avenue
Rye Brook, NY 10573

Ownership History

Curemark, LLC

Original Applicant
16
Rye Brook, NY

Curemark, LLC

Owner at Publication
16
Rye Brook, NY

Curemark, LLC

Original Registrant
16
Rye Brook, NY

Legal Representation

Attorney
Nicole K. McLaughlin

USPTO Deadlines

Next Deadline
601 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20210817)
Due Date
August 17, 2027
Grace Period Ends
February 17, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

13 events
Date Code Type Description Documents
Aug 17, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jun 1, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 1, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 12, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 3, 2021 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
May 3, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
May 3, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
May 3, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
May 3, 2021 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Apr 27, 2021 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 26, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 15, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 19, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for the diagnosis, treatment and prevention of viral, bacterial, fungal, parasitic metabolic, endocrine, hepatological, respiratory, nervous system, neurological, gastrointestinal, digestive, inflammatory, pulmonary, hormonal, dermatological, psychiatric, addictive, behavioral, infectious, addictive, musculoskeletal, cardiovascular, ophthalmic, cardiopulmonary, genitourinary, sexual dysfunction, oncological and immune system related diseases and disorders; pharmaceutical preparations for the treatment and prevention of Influenza, Coronaviruses, pancreatic deficiencies, gastrointestinal disease, internal malabsorption syndromes, Autism, Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder and Williams Syndrome; Antibacterial, antiviral and antifungal preparations for skin and wound healing; disinfectants and antiseptics; antimicrobial cleansers for sanitation purposes; Medical assays for testing of bodily fluids and tissues for testing of enzymes in humans; biological preparations for medical testing; diagnostic preparations for medical purposes; testing kits comprised of medical diagnostic reagents and assays for testing enzymes and body fluids for use in disease detection; medical diagnostic reagents and assays for testing of enzymes and body fluids; chemical preparations for medical testing; diagnostic biomarker reagents for medical testing; all the foregoing for the diagnosis and treatment of viral, bacterial, fungal, parasitic metabolic, endocrine, hepatological, respiratory, nervous system, neurological, gastrointestinal, digestive, inflammatory, pulmonary, hormonal, dermatological, psychiatric, addictive, behavioral, infectious, addictive, musculoskeletal, cardiovascular, ophthalmic, cardiopulmonary, genitourinary, sexual dysfunction, oncological and immune system related diseases and disorders
First Use Anywhere: Dec 2, 2009
First Use in Commerce: Dec 2, 2009
Class 042
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical and pharmaceutical research; Development of pharmaceuticals and medical devices for others; Providing temporary use of non-downloadable computer software that allows users to make determinations regarding neurological diseases, specifically baseline staging, data gathering and monitoring of early, middle and late stage neurological diseases; Design and development of medical assays for others; clinical research and development of treatments for viral, bacterial, fungal, parasitic metabolic, endocrine, hepatological, respiratory, nervous system, neurological, gastrointestinal, digestive, inflammatory, pulmonary, hormonal, dermatological, psychiatric, addictive, behavioral, infectious, addictive, musculoskeletal, cardiovascular, ophthalmic, cardiopulmonary, genitourinary, sexual dysfunction, oncological and immune system related diseases and disorders; clinical research and development of treatments for the treatment and prevention of Influenza, Coronaviruses, pancreatic deficiencies, gastrointestinal disease, internal malabsorption syndromes, Autism, Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder and Williams Syndrome; clinical research and development of treatments for antibacterial, antiviral, and antifungal preparations for skin and wound healing; clinical research and development of disinfectants, antiseptics and antimicrobial cleansers for sanitation purposes; medical and scientific research services in the field of digestion and detection of enzymes or biological substances in the body
First Use Anywhere: Dec 2, 2009
First Use in Commerce: Dec 2, 2009
Class 044
Medical testing for diagnostic and treatment purposes; Medical consultations; medical testing for diagnostic treatment purposes in the fields of viral, bacterial, fungal, parasitic metabolic, endocrine, hepatological, respiratory, nervous system, neurological, gastrointestinal, digestive, inflammatory, pulmonary, hormonal, dermatological, psychiatric, addictive, behavioral, infectious, addictive, musculoskeletal, cardiovascular, ophthalmic, cardiopulmonary, genitourinary, sexual dysfunction, oncological and immune system related diseases and disorders; medical testing for diagnostic treatment and prevention of Influenza, Coronaviruses, pancreatic deficiencies, gastrointestinal disease, internal malabsorption syndromes, Autism, Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder and Williams Syndrome; Medical diagnostic testing, monitoring and reporting services; performing diagnosis of diseases; Health care services, namely, the administration of medical assays for the detection of enzymes in humans
First Use Anywhere: Dec 2, 2009
First Use in Commerce: Dec 2, 2009

Additional Information

Design Mark
The mark consists of stylized version of the letter "C".

Classification

International Classes
005 042 044